Literature DB >> 24681094

Colonic wall changes in patients with diverticular disease - is there a predisposition for a complicated course?

T F Ulmer1, R Rosch2, A Mossdorf2, H Alizai2, M Binnebösel2, U Neumann2.   

Abstract

BACKGROUND: The aim of this study was to evaluate colonic wall changes and enteric neuropathy in patients with either uncomplicated (UDD) or complicated diverticular disease (CDD). Furthermore, we evaluated the presence of an anatomic sphincter at the rectosigmoid junction (RSJ).
METHODS: Samples of colonic tissue from fifteen patients with UDD, fifteen patients with CDD and fifteen patients as control were collected. Collagen quotient I/III was measured with the Sirius-red test, expression of MMP-1, MMP-13, innervation (S100), proliferation (Ki67) and apoptosis (TUNEL) in the colonic wall were investigated by immunohistochemical studies. Furthermore, measurements of the different layers were performed to investigate the RSJ.
RESULTS: Patients with either UDD or CDD had lower collagen I/III quotients compared to the control group, significant for CDD (p = 0.007). For MMP-1 and MMP-13 only a slight increase for patients with CDD was found. The percentage of proliferating (Ki67) and apoptotic (TUNEL) cells was significantly higher for patients with CDD than in the control group (p = 0.016; p = 0.037). Upon investigating the S100-expression a significant reduce in glial cells density was found in the myenteric and mucosal plexus for both groups (UDD and CDD) compared to the control group. Measurements of the different colon layers oral, aboral and at the RSJ revealed equal values.
CONCLUSIONS: This study has shown that colonic wall changes and enteric neuropathy seem to play a role in the pathogenesis of colonic diverticulosis. None of our results suggest a predisposition for a complicated diverticular disease. Furthermore, the presence of an anatomic sphincter at the rectosigmoid junction could not be detected.
Copyright © 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diverticular disease; Diverticulitis; Enteric neuropathy; Extracellular matrix; Matrix metalloproteinase; Sphincter

Mesh:

Substances:

Year:  2014        PMID: 24681094     DOI: 10.1016/j.ijsu.2014.03.014

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  8 in total

1.  Diverticular disease: paradigm shifts in pathogenesis and treatment.

Authors:  Keta K Vaidya; Martin H Floch
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

2.  Surgical diverticulitis is not associated with defects in the expression of wound healing genes.

Authors:  Tara M Connelly; Arthur S Berg; Leonard R Harris; Rafel Tappouni; Dave Brinton; Sue Deiling; Walter A Koltun
Journal:  Int J Colorectal Dis       Date:  2015-05-24       Impact factor: 2.571

Review 3.  Evaluation of molecular and genetic predisposing parameters at diverticular disease of the colon.

Authors:  Aikaterini Mastoraki; Dimitrios Schizas; Athina Tousia; George Chatzopoulos; Anastasia Gkiala; Athanasios Syllaios; Maximos Frountzas; Pantelis Vassiliu; Georgios E Theodoropoulos; Evangelos Felekouras
Journal:  Int J Colorectal Dis       Date:  2021-01-07       Impact factor: 2.571

4.  Bacterial stimuli activate nitric oxide colonic mucosal production in diverticular disease. Protective effects of L. casei DG® (Lactobacillus paracasei CNCM I-1572).

Authors:  Fabio Turco; Paolo Andreozzi; Ilaria Palumbo; Francesco Paolo Zito; Martina Cargiolli; Walter Fiore; Nicola Gennarelli; Giovanni Domenico De Palma; Giovanni Sarnelli; Rosario Cuomo
Journal:  United European Gastroenterol J       Date:  2016-12-11       Impact factor: 4.623

Review 5.  Management of sigmoid diverticulitis: an update.

Authors:  Patrick Ambrosetti; Pascal Gervaz
Journal:  Updates Surg       Date:  2016-04-16

6.  Myenteric plexitis: A frequent feature in patients undergoing surgery for colonic diverticular disease.

Authors:  Gabrio Bassotti; Vincenzo Villanacci; Angelo Sidoni; Riccardo Nascimbeni; Maria P Dore; Gian A Binda; Roberto Bandelloni; Marianna Salemme; Rachele Del Sordo; Moris Cadei; Alessandra Manca; Nunzia Bernardini; Christoph A Maurer; Gieri Cathomas
Journal:  United European Gastroenterol J       Date:  2015-12       Impact factor: 4.623

7.  Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.

Authors:  Raquel G F Costa; Paula L Caro; Emídio M de Matos-Neto; Joanna D C C Lima; Katrin Radloff; Michele J Alves; Rodolfo G Camargo; Ana Flávia M Pessoa; Estefania Simoes; Patrícia Gama; Denise C Cara; Aloísio S F da Silva; Welbert O Pereira; Linda F Maximiano; Paulo S M de Alcântara; José P Otoch; Giorgio Trinchieri; Alessandro Laviano; Maurizio Muscaritoli; Marília Seelaender
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-07-15       Impact factor: 12.910

8.  MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy-dependent mechanism.

Authors:  Ming Qi; Simeng Liao; Jing Wang; Yuankun Deng; Andong Zha; Yirui Shao; Zhijuan Cui; Tongxing Song; Yulong Tang; Bie Tan; Yulong Yin
Journal:  J Cachexia Sarcopenia Muscle       Date:  2021-11-22       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.